BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37566970)

  • 1. Molecular detection of multidrug-resistant Pseudomonas aeruginosa of different avian sources with pathogenicity testing and in vitro evaluation of antibacterial efficacy of silver nanoparticles against multidrug-resistant P. aeruginosa.
    Marouf S; Li X; Salem HM; Ahmed ZS; Nader SM; Shaalan M; Awad FH; Zhou H; Cheang T
    Poult Sci; 2023 Oct; 102(10):102995. PubMed ID: 37566970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination of mcr-1 and β-lactamase genes among Pseudomonas aeruginosa: molecular characterization of MDR strains in broiler chicks and dead-in-shell chicks infections.
    Salem M; Younis G; Sadat A; Nouh NAT; Binjawhar DN; Abdel-Daim MM; Elbadawy M; Awad A
    Ann Clin Microbiol Antimicrob; 2024 Jan; 23(1):9. PubMed ID: 38281970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of carbapenemases bla
    Haider MH; McHugh TD; Roulston K; Arruda LB; Sadouki Z; Riaz S
    Ann Clin Microbiol Antimicrob; 2022 May; 21(1):18. PubMed ID: 35590320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo and in Vitro activity of colistin-conjugated bimetallic silver-copper oxide nanoparticles against Pandrug-resistant Pseudomonas aeruginosa.
    Abdul Hak A; Zedan HH; El-Mahallawy HA; El-Sayyad GS; Zafer MM
    BMC Microbiol; 2024 Jun; 24(1):213. PubMed ID: 38886632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.
    de Lacerda Coriolano D; de Souza JB; Bueno EV; Medeiros SMFRDS; Cavalcanti IDL; Cavalcanti IMF
    Braz J Microbiol; 2021 Mar; 52(1):267-278. PubMed ID: 33231865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-Resistance Genes in Pseudomonas aeruginosa from Wound Infections in a Tertiary Health Institution in Osogbo, Nigeria.
    Akinloye AO; Adefioye JO; Adekunle CO; Anomneze BU; Makanjuola OB; Onaolapo OJ; Onaolapo AY; Olowe OA
    Infect Disord Drug Targets; 2021; 21(1):90-98. PubMed ID: 31957616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antimicrobial activity of silver nanoparticles produced via a green chemistry synthesis using
    Escárcega-González CE; Garza-Cervantes JA; Vázquez-Rodríguez A; Montelongo-Peralta LZ; Treviño-González MT; Díaz Barriga Castro E; Saucedo-Salazar EM; Chávez Morales RM; Regalado Soto DI; Treviño González FM; Carrazco Rosales JL; Cruz RV; Morones-Ramírez JR
    Int J Nanomedicine; 2018; 13():2349-2363. PubMed ID: 29713166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of virulence and drug resistance genes-producing Escherichia coli isolated from chicken meat: Metal oxide nanoparticles as novel antibacterial agents.
    Ali SS; Sonbol FI; Sun J; Hussein MA; Hafez AE; Abdelkarim EA; Kornaros M; Ali A; Azab M
    Microb Pathog; 2020 Jun; 143():104164. PubMed ID: 32198092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial efficacy of silver nanoparticles against metallo-β-lactamase (blaNDM, blaVIM, blaOXA) producing clinically isolated Pseudomonas aeruginosa.
    Qureshi R; Qamar MU; Shafique M; Muzammil S; Rasool MH; Ahmad I; Ejaz H
    Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):237-243. PubMed ID: 34275847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant
    Liao S; Zhang Y; Pan X; Zhu F; Jiang C; Liu Q; Cheng Z; Dai G; Wu G; Wang L; Chen L
    Int J Nanomedicine; 2019; 14():1469-1487. PubMed ID: 30880959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Properties of Ag-Cu Alloy Nanoparticles Against Multidrug-Resistant
    Pourjafari M; Ghane M; Kaboosi H; Sadeghi B; Rezaei A
    J Biomed Nanotechnol; 2022 Apr; 18(4):1196-1204. PubMed ID: 35854448
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibiotic resistance and virulent factors in nosocomial clinical isolates of Pseudomonas aeruginosa from Panamá.
    Sambrano H; Castillo JC; Ramos CW; de Mayorga B; Chen O; Durán O; Ciniglio C; Aguilar C; Cisterna O; de Chial M
    Braz J Infect Dis; 2021; 25(1):101038. PubMed ID: 33285136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital.
    Weber C; Schultze T; Göttig S; Kessel J; Schröder A; Tietgen M; Besier S; Burbach T; Häussler S; Wichelhaus TA; Hack D; Kempf VAJ; Hogardt M
    Microbiol Spectr; 2022 Oct; 10(5):e0169722. PubMed ID: 36190424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant
    Sid Ahmed MA; Hamid JM; Husain AA; Hadi HA; Skariah S; Sultan AA; Ibrahim EB; Al Khal AL; Soderquist B; Jass J; Omrani AS
    Ann Med; 2021 Dec; 53(1):2345-2353. PubMed ID: 34882052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial efficacy of silver nanoparticles against multi-drug resistant clinical isolates from post-surgical wound infections.
    Kasithevar M; Periakaruppan P; Muthupandian S; Mohan M
    Microb Pathog; 2017 Jun; 107():327-334. PubMed ID: 28411059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary.
    O'Neall D; Juhász E; Tóth Á; Urbán E; Szabó J; Melegh S; Katona K; Kristóf K
    Acta Microbiol Immunol Hung; 2020 Mar; 67(1):61-65. PubMed ID: 32208923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of synergistic antimicrobial resistance mechanisms in clinical isolates of Pseudomonas aeruginosa from post-operative wound infections.
    Awan AB; Yan A; Sarwar Y; Schierack P; Ali A
    Appl Microbiol Biotechnol; 2021 Dec; 105(24):9321-9332. PubMed ID: 34797390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Antibacterial Effects of Titanium Dioxide Nanoparticles Alone and in Combination with Antibiotics on MDR
    Ahmed FY; Farghaly Aly U; Abd El-Baky RM; Waly NGFM
    Int J Nanomedicine; 2020; 15():3393-3404. PubMed ID: 32523339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
    Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
    Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.